German OTC Marketing Round-Up: Allergy Launches From Novartis, Hevert, Dermapharm And Bencard
OTC marketing news from Germany: A hard-won desloratadine launch from Novartis, two new products from Dermapharm, as well as homeopathic and probiotic alternatives from Hevert and Bencard.
You may also be interested in...
Generics giant Novartis through its Hexal subsidiary has won an important case against the German Ministry of Health over a delayed prescription-to-OTC switch of desloratadine, which shows European Union Member States have got the authority to switch at a national level centrally authorized drugs.
New OTC products and campaigns for the hay fever season from: GSK, Novartis, Dermapharm, Galenpharma, DHU and Thea Pharma.
UK R&D company Futura Medical's new CBD gel shows great potential as an effective cosmetic or even as a new kind of anti-inflammatory medicinal product.